Pharmadil
ActiveSummary
The computed 12-month bankruptcy probability of Pharmadil is 7.5% (elevated). For Pharmadil, one filing cycle of the annual accounts is missing. The 2024 annual accounts show negative equity (-€88,047) and a net result of -€69,128. Equity is shrinking by ~62% per year across the filed fiscal years. Its solvency ranks better than 8% of 9,655 sector peers (NACE 47, fiscal year 2024). The company has been active since 2014 and the Belgian State Gazette contains no insolvency or warning signals.
Register details
Identification
Legal formPrivate limited company
Founded28-03-2014
Fiscal year end31-03
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
E-invoicing
Reachable via Peppol
Peppol ID
0208:0549774521
Also
9925:BE0549774521
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 7 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Sites & property
Location & real-estate footprint
Registered office, Dilbeek · 1 establishment unit since 2014
Ground area
1,110 m²
Building footprint
312 m²
Volume, LiDAR
2,434 m³
2 parcels, Flanders · tallest building 11.7 m, ±3 floors. Linked by address, not a title deed.
2
companies at this address
See who is registered here
1 establishment unit
Pharmadil
since 2014unit no. 2.229.641.010
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 23016D0215/00E006 | Flanders | 634 m² | 1 · 194 m² | 11.7 m · 3 fl. |
| 23352F0220/00R005 | Flanders | 476 m² | 1 · 118 m² | 10.1 m · 3 fl. |
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.